(Q74055987)
Statements
Serum-soluble fas level determines clinical symptoms and outcome of patients with aggressive non-Hodgkin's lymphoma (English)
T Hara
H Tsurumi
M Takemura
H Goto
T Yamada
M Sawada
T Takahashi
scientific article published on 01 August 2000